Q4 2024 Healthcare Global Enterprises Ltd Earnings Call Transcript
Key Points
- HealthCare Global Enterprises Ltd (BOM:539787) reported a 12% year-on-year revenue growth for Q4 2024, with EBITDA growth of 21%, translating to a 19% EBITDA margin.
- The company has achieved several clinical milestones, including record numbers of minimal access head and neck surgeries and rare procedures like NeuroSAFE and robotic-assisted breast-axillo thyroidectomy.
- HealthCare Global Enterprises Ltd (BOM:539787) continues to expand its state-of-the-art technology offerings, including digital PET scans, precision radiation therapy, and cutting-edge robotic surgery systems.
- The company has introduced the HCG CARE smart app suite, which has benefited over 56,000 outpatients and includes active participation from more than 300 doctors.
- HealthCare Global Enterprises Ltd (BOM:539787) has a strong focus on research and development, establishing an institutional research committee to fund investigator-initiated trials, a unique initiative in the Indian private health sector.
- The company's nascent centers currently have low or negative ROCE, which could impact overall financial performance.
- There has been a decline in capacity utilization from 65% to 61% due to proactive expansion and the incorporation of four new linear accelerators.
- The effective tax rate for FY '25 is expected to be between 35% to 39%, which is relatively high.
- HealthCare Global Enterprises Ltd (BOM:539787) faces challenges in ramping up new bed capacities quickly, as seen in the Ahmedabad center.
- The company has significant debt levels, with net debt excluding leases standing at INR358 crores as of March 2024, which includes acquisitions and growth CapEx.
Ladies and gentlemen, good day, and welcome to the Q4 and FY '24 earnings conference call of HealthCare Global Enterprises Limited.
This conference call may contain forward-looking statements about the company, which are based on the beliefs, opinions and expectations of the company as on date of this call.
These statements are not the guarantees of the future performance of the company, and it may involve risks and uncertainties that are difficult to predict. (Operator Instructions). Please note that this conference is being recorded.
I now hand the conference over to Dr. B.S. Ajaikumar, Executive Chairman of HealthCare Global Enterprises Limited. Thank you, and over to you, sir.
Thank you very much, and good morning to everyone, and a warm welcome to the present Q4 '24 FY '24 earnings conference call for HealthCare Global Enterprise. I'm joined today by Mr. Raj Gore, our CEO; and Ruby Ritolia, CFO; and my senior management team, along with
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
